Postmenopausal vaginal atrophy and atrophic vaginitis

被引:130
作者
Pandit, L
Ouslander, JG
机构
[1] EMORY UNIV, WESLEY WOODS GERIATR CTR, VET ADM REHABIL RES & DEV CTR, ATLANTA, GA 30329 USA
[2] EMORY UNIV, SCH MED, DIV GERIATR MED & GERONTOL, ATLANTA, GA 30329 USA
[3] EMORY UNIV, WESLEY WOODS GERIATR CTR, DIV GERIATR MED & GERONTOL, ATLANTA, GA 30329 USA
关键词
postmenopausal; vaginal atrophy; atrophic vaginitis; estrogen replacement;
D O I
10.1097/00000441-199710000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Menopause is associated with a marked reduction in endogenous estrogen production, Lower levels of circulating blood estrogen have various deleterious effects, including those on the lower urinary tract. The vaginal epithelium becomes atrophied and dry, which can cause vaginal discomfort, itching, and dyspareunia. The epithelium may become inflamed and contribute to urinary symptoms, including frequency, urgency, dysuria, and incontinence. Diminished estrogen effects on periurethral tissues can contribute to pelvic laxity and stress incontinence. Changes in vaginal pH and normal flora may predispose older women to urinary tract infection. Although estrogen replacement therapy can result in maturation of the vaginal epithelium, the optimal form of administration and the dosage regimen for improving symptoms and quality of life of the geriatric female population have not been well studied.
引用
收藏
页码:228 / 231
页数:4
相关论文
共 28 条
[1]   Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy [J].
Barentsen, R ;
vandeWeijer, PHM ;
Schram, JHN .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 71 (01) :73-80
[2]  
BRANDBERG A, 1987, ACTA OBSTET GYN SCAN, P33
[3]  
BROWN KH, 1997, UROGENITAL ATROPHY, V15, P13
[4]   Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women [J].
Bygdeman, M ;
Swahn, ML .
MATURITAS, 1996, 23 (03) :259-263
[5]   COMPARATIVE ENDOCRINOLOGIC AND CLINICAL EFFECTS OF PERCUTANEOUS ESTRADIOL AND ORAL CONJUGATED ESTROGENS AS REPLACEMENT THERAPY IN MENOPAUSAL WOMEN [J].
DUPONT, A ;
DUPONT, P ;
CUSAN, L ;
TREMBLAY, M ;
RIOUX, J ;
CLOUTIER, D ;
MAILLOUX, J ;
DELIGNIERES, B ;
GUTKOWSKA, J ;
BOUCHER, H ;
BELANGER, A ;
MOYER, DL ;
MOORJANI, S ;
LABRIE, F .
MATURITAS, 1991, 13 (04) :297-311
[6]  
EIERMANN W, 1986, P INT WORKSH COP NOV
[7]   PLASMA-LEVELS OF ESTRONE, ESTRADIOL AND GONADOTROPINS IN POST-MENOPAUSAL WOMEN AFTER ORAL AND VAGINAL ADMINISTRATION OF CONJUGATED EQUINE ESTROGENS (PREMARIN) [J].
ENGLUND, DE ;
JOHANSSON, EDB .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1978, 85 (12) :957-964
[8]   PHARMACOKINETICS AND PHARMACODYNAMIC EFFECTS OF VAGINAL ESTRADIOL ADMINISTRATION FROM SILASTIC RINGS IN POST-MENOPAUSAL WOMEN [J].
ENGLUND, DE ;
VICTOR, A ;
JOHANSSON, EDB .
MATURITAS, 1981, 3 (02) :125-133
[9]   LOW-DOSE 17-BETA-ESTRADIOL VAGINAL TABLETS IN THE TREATMENT OF ATROPHIC VAGINITIS - A DOUBLE-BLIND PLACEBO CONTROLLED-STUDY [J].
ERIKSEN, PS ;
RASMUSSEN, H .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1992, 44 (02) :137-144
[10]  
ESKIN BA, 1994, MENOPAUSE COMPREHENS, P382